<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36966161</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>25</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>A prospective cohort study assessing the relationship between long-COVID symptom incidence in COVID-19 patients and COVID-19 vaccination.</ArticleTitle><Pagination><StartPage>4896</StartPage><MedlinePgn>4896</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">4896</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-30583-2</ELocationID><Abstract><AbstractText>Current studies about the long-term effects of COVID-19 show a wide range of symptoms. This prospective cohort study aimed to find the incidence of long-COVID symptoms and the associated risk factors. We followed 669 confirmed COVID-19 patients. Sociodemographic and clinical data were extracted from medical records and collected via semi-structured telephone interviews on days 10, 30, 60, and 90. The incidence of long-COVID symptoms was 41.6% (95% CI 37.8-45.4%). Females [aOR&#x2009;=&#x2009;1.5 (95% CI 1.1-2.3)], the elderly [aOR&#x2009;=&#x2009;4.9 (95% CI 2.0-11.3)], and those who required hospitalization [aOR&#x2009;=&#x2009;5.0 (95% CI 1.3-3.7)] were at a higher risk of developing long-COVID. Patients with dyspnea at day 10 [aOR: 2.4 (95% CI 1.6-3.7] and fatigue at day 60 [aOR: 3.1 (95% CI 1.5-6.3] were also at risk. While non-vaccinated patients were almost seven times more likely to report long-COVID symptoms than vaccinated patients [aOR: 6.9 (95% CI 4.2-11.3)]. In conclusion, long-COVID was common among COVID-19 patients, with higher rates among females, older age groups, hospitalized patients, and those with dyspnea and fatigue, while vaccination provided protection. Interventions should educate health professionals, raise general public awareness about the risks and consequences of Long COVID, and the value of vaccination.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abu Hamdh</LastName><ForeName>Bayan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Public Health, Faculty of Graduate Studies, An-Najah National University, Nablus, Palestine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazzal</LastName><ForeName>Zaher</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-2655-6109</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Box 7707, Nablus, Palestine. znazzal@najah.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>19</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>25</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36966161</ArticleId><ArticleId IdType="pmc">PMC10039348</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-30583-2</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-30583-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lu H, Stratton CW, Tang Y-W. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J. Med. Virol. 2020;92:401&#x2013;402. doi: 10.1002/jmv.25678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25678</ArticleId><ArticleId IdType="pmc">PMC7166628</ArticleId><ArticleId IdType="pubmed">31950516</ArticleId></ArticleIdList></Reference><Reference><Citation>occupied Palestinian territory, including east Jerusalem: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. https://covid19.who.int/region/emro/country/ps (Accessed 17 October 2022) (2022).</Citation></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. Lancet Reg. Heal.&#x2014;Eur. 2021;6:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Post-COVID Conditions: Information for Healthcare Providers. U.S. Department of Health &amp; Human Services 2021; 2019&#x2013;2021.</Citation></Reference><Reference><Citation>World Health Organization. Post COVID-19 condition (Long COVID). https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition (Accessed 8 December 2022) (2022).</Citation></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan S, Khunti K, Alwan N, et al. In the wake of the pandemic: Preparing for Long COVID. In the wake of the pandemic: Preparing for Long COVID. https://apps.who.int/iris/bitstream/handle/10665/339629/Policy-brief-39-1997-8073-eng.pdf (Accessed 8 August 2022) (2021).</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, et al. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. Epub ahead of print 2023. DOI: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Collaborators GB, of DLC. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604&#x2013;1615. doi: 10.1001/jama.2022.18931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, March&#x2013;June 2020. MMWR Morb. Mortal Wkly. Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J. Med. Virol. 2021;93:1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Righi E, Mirandola M, Mazzaferri F, et al. Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study. J. Infect. 2022;84:566&#x2013;572. doi: 10.1016/j.jinf.2022.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.02.003</ArticleId><ArticleId IdType="pmc">PMC8828388</ArticleId><ArticleId IdType="pubmed">35150765</ArticleId></ArticleIdList></Reference><Reference><Citation>Dryden M, Mudara C, Vika C, et al. Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: A prospective cohort study. Lancet Glob. Health. 2022;10:e1247&#x2013;e1256. doi: 10.1016/S2214-109X(22)00286-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(22)00286-8</ArticleId><ArticleId IdType="pmc">PMC9363040</ArticleId><ArticleId IdType="pubmed">35961348</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. SSRN Electron J. Epub ahead of print 2021. DOI: 10.2139/ssrn.3820561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V-T, Porcher R, Pane I, et al. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat. Commun. 2022;13:1812. doi: 10.1038/s41467-022-29513-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisaccia G, Ricci F, Recce V, et al. Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know? J Cardiovasc Dev Dis; 8. Epub ahead of print November 2021. DOI: 10.3390/jcdd8110156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8621226</ArticleId><ArticleId IdType="pubmed">34821709</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazukhina E, Andreeva M, Spiridonova E, et al. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: A prospective, cohort study in Moscow (Stop COVID) SSRN Electron. J. 2022;20:244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9257572</ArticleId><ArticleId IdType="pubmed">35794549</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Gonz&#xe1;lez A, Ara&#xfa;jo-Ameijeiras A, Fern&#xe1;ndez-Villar A, et al. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. Sci. Rep. 2022;12:3369. doi: 10.1038/s41598-022-07414-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07414-x</ArticleId><ArticleId IdType="pmc">PMC8888560</ArticleId><ArticleId IdType="pubmed">35233035</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, et al. Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study. Open Forum Infect. Dis. 2022;9(9):ofac464. doi: 10.1093/ofid/ofac464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac464</ArticleId><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: A prospective, community-based, nested, case-control study. Lancet Infect. Dis. 2022;22:43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections. Brain Behav. Immun. 2022;103:154&#x2013;162. doi: 10.1016/j.bbi.2022.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. eClinicalMedicine; 53. Epub ahead of print 1 November 2022. DOI: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L, Tosto-Mancuso J, Wood J, et al. Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am. J. Phys. Med. Rehabil. 2022;101:48&#x2013;52. doi: 10.1097/PHM.0000000000001910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001910</ArticleId><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajiro T, Nishimura K, Tsukino M, et al. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998;158:1185&#x2013;1189. doi: 10.1164/ajrccm.158.4.9802091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.158.4.9802091</ArticleId><ArticleId IdType="pubmed">9769280</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova C, Marin JM, Martinez-Gonzalez C, et al. Differential effect of modified medical research council dyspnea, COPD assessment test, and clinical COPD questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD. Chest. 2015;148:159&#x2013;168. doi: 10.1378/chest.14-2449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.14-2449</ArticleId><ArticleId IdType="pubmed">25612228</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendriks C, Drent M, Elfferich M, et al. The fatigue assessment scale: Quality and availability in sarcoidosis and other diseases. Curr. Opin. Pulm. Med. 2018;24:1.</Citation><ArticleIdList><ArticleId IdType="pubmed">29889115</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain N, Samuelsson CM, Drummond A, et al. Prevalence of fatigue at one-year follow-up from the Gothenburg recovery and rehabilitation after COVID-19 and intensive care unit study. Sci. Rep. 2022;12:11501. doi: 10.1038/s41598-022-14787-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-14787-6</ArticleId><ArticleId IdType="pmc">PMC9276681</ArticleId><ArticleId IdType="pubmed">35821226</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hanbali S, Aljasser A, Aboudi O, et al. Establishing the reliability and the validity of the Arabic translated versions of the effort assessment scale and the fatigue assessment scale. Int. J. Audiol. 2022 doi: 10.1080/14992027.2022.2085195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14992027.2022.2085195</ArticleId><ArticleId IdType="pubmed">35767227</ArticleId></ArticleIdList></Reference><Reference><Citation>da Prestes GS, Simon CS, Walz R, et al. Respiratory outcomes after 6 months of hospital discharge in patients affected by COVID-19: A prospective cohort. Front. Med. 2022;9:1&#x2013;7. doi: 10.3389/fmed.2022.795074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.795074</ArticleId><ArticleId IdType="pmc">PMC8936421</ArticleId><ArticleId IdType="pubmed">35321473</ArticleId></ArticleIdList></Reference><Reference><Citation>Osikomaiya B, Erinoso O, Wright KO, et al. &#x2018;Long COVID&#x2019;: Persistent COVID-19 symptoms in survivors managed in Lagos State Nigeria. BMC Infect. Dis. 2021;21:1&#x2013;7. doi: 10.1186/s12879-020-05716-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05716-x</ArticleId><ArticleId IdType="pmc">PMC7993075</ArticleId><ArticleId IdType="pubmed">33765941</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira-Santos D, Maranh&#xe3;o P, Monteiro-Soares M. Identifying common baseline clinical features of COVID-19: A scoping review. BMJ Open. 2020;10:e041079. doi: 10.1136/bmjopen-2020-041079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-041079</ArticleId><ArticleId IdType="pmc">PMC7496569</ArticleId><ArticleId IdType="pubmed">32938604</ArticleId></ArticleIdList></Reference><Reference><Citation>Olumade TJ, Uzairue LI. Clinical characteristics of 4499 COVID-19 patients in Africa: A meta-analysis. J. Med. Virol. 2021;93:3055&#x2013;3061. doi: 10.1002/jmv.26848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26848</ArticleId><ArticleId IdType="pmc">PMC8013423</ArticleId><ArticleId IdType="pubmed">33543800</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin. Microbiol. Infect. 2021;27:258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodeir MM, Shabana HA, Rasheed Z, et al. COVID-19: Post-recovery long-term symptoms among patients in Saudi Arabia. PLoS ONE. 2021;16:1&#x2013;16. doi: 10.1371/journal.pone.0260259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260259</ArticleId><ArticleId IdType="pmc">PMC8654233</ArticleId><ArticleId IdType="pubmed">34879074</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez JM, et al. Post-acute COVID-19 syndrome incidence and risk factors: A mediterranean cohort study. J. Infect. 2021;82:378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Almasri M-S, Alqaisi R, Al-Shagahin M, et al. Risk factors and characterization of post-COVID-19 syndrome in Jordan. Iproceedings. 2022;8:e36563. doi: 10.2196/36563.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/36563</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnachie E, Hapfelmeier A, Linde K, et al. Incidence of post-COVID syndrome and associated symptoms in outpatient care in Bavaria, Germany: A retrospective cohort study using routinely collected claims data. BMJ Open. 2022;12:e064979. doi: 10.1136/bmjopen-2022-064979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-064979</ArticleId><ArticleId IdType="pmc">PMC9511014</ArticleId><ArticleId IdType="pubmed">36137635</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedberg P, Granath F, Bruchfeld J, et al. Post COVID-19 condition diagnosis: A population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection. J. Intern. Med. 2023;293:246&#x2013;258. doi: 10.1111/joim.13584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13584</ArticleId><ArticleId IdType="pmc">PMC9877994</ArticleId><ArticleId IdType="pubmed">36478477</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Akbari A, Emami A, et al. Risk factors associated with long covid syndrome: A retrospective study. Iran. J. Med. Sci. 2021;46:428&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, et al. Fatigue and dyspnoea as main persistent post-COVID-19 symptoms in previously hospitalized patients: Related functional limitations and disability. Respiration. 2022;101:132&#x2013;141. doi: 10.1159/000518854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000518854</ArticleId><ArticleId IdType="pmc">PMC8678253</ArticleId><ArticleId IdType="pubmed">34569550</ArticleId></ArticleIdList></Reference><Reference><Citation>covidvax.live &#x2013; Palestine. https://covidvax.live/location/pse (Accessed 13 October 2022).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>